Login / Signup

Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma.

Salih DemirNegin RazizadehÉmilie IndersieSophie BranchereauStefano CairoRoland Kappler
Published in: Hepatology communications (2024)
The inhibition of UHRF1-associated epigenetic traces, such as IGF2-mediated survival, is an attractive approach to treat high-risk HB, especially when combined with the standard-of-care therapeutic cisplatin.
Keyphrases
  • dna methylation
  • healthcare
  • binding protein
  • free survival
  • gene expression
  • palliative care
  • pi k akt
  • quality improvement
  • growth hormone
  • drug delivery